Clinically shown to visibly lighten age spots in 8 weeks through independent image analysis.
In an independent 8-week study of 35 women (ages 48–70, mean 62.8), VISIA-CR 5 image analysis showed age-spot mean intensity improved +7.07% vs baseline, with 79.41% of participants improving (p < 0.0001). Higher VISIA intensity means lighter pigmentation, so the increase represents visible lightening of age spots. No adverse events across the study. Conducted by International Research Service, Inc. (IRSI Inc.), an ALS Global company; Principal Investigator Barry T. Reece, M.S., M.B.A.
At Week 8, participants also reported (all statistically significant): 82.9% smoother skin, 82.9% firmer skin, 82.9% more radiant, 80.0% would buy, 80.0% would recommend, 88.6% safe for daily use.